Entero Therapeutics, Inc. (ENTO) Net Income by Year
Entero Therapeutics, Inc. reported a net loss of $6.4M in fiscal year 2025. This represents an increase of 64.6% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Entero Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ENTO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ENTO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Entero Therapeutics, Inc. financials
Frequently Asked Questions
What was Entero Therapeutics, Inc.'s net income in fiscal year 2025?
Entero Therapeutics, Inc. reported a net loss of $6.4M in fiscal year 2025.
How fast is Entero Therapeutics, Inc.'s net income growing?
Entero Therapeutics, Inc. (ENTO) net income rose by 64.6% year over year, from -$18.1M to -$6.4M in fiscal year 2025.
How has Entero Therapeutics, Inc.'s net income changed over the years?
Across the 11 fiscal years this page covers, Entero Therapeutics, Inc. (ENTO) net income went from -$5.9M in fiscal year 2015 to -$6.4M in fiscal year 2025.
What was Entero Therapeutics, Inc.'s net income in the most recent quarter?
Entero Therapeutics, Inc. (ENTO) reported -$3.4M in net income in Q1 2026. This represents a decrease of 173.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Entero Therapeutics, Inc. (ENTO) reported on that line in every period on record.